Insulin restores gut health and microbiota loads as well as IL-22 production, prevents microbiota encroachment, and protects against HFD-induced low-grade inflammation (LGI) and metabolic syndrome in an IL-22-dependent microbiota manner. Here, IL22 is linked to metabolic syndrome.